1CELL
The 1CELL science

Regenerative biology, backed by evidence.

Every biological is characterized, documented and delivered with full traceability.

1CELL laboratory
MSC — Multipotency with per-batch evidence.

Mesenchymal stem cells

MSC — Multipotency with per-batch evidence.

Multipotent cells with differentiation and paracrine modulation capacity.

  • Viability ≥ 95% (7-AAD / Trypan)
  • CD73+ CD90+ CD105+ · CD34− CD45−
  • Presentations 50M · 100M · 200M
  • cGMP culture with controlled passages
Method · Characterization by multicolor flow cytometry.
Exosomes & Secretome — High-purity regenerative signaling.

Extracellular vesicles

Exosomes & Secretome — High-purity regenerative signaling.

30–150 nm vesicles carrying proteins, lipids and regulatory RNA.

  • 10¹⁰–10¹² particles per vial
  • CD9+ CD63+ CD81+ confirmed
  • Low protein contamination
  • Tangential-flow ultrafiltration
Method · Quantification by NTA and tetraspanin ELISA.
Natural Killer — Characterized immune surveillance.

Cellular immunotherapy

Natural Killer — Characterized immune surveillance.

CD56+ CD3− populations with a validated cytotoxic profile.

  • NK purity ≥ 90%
  • Functional cytotoxic activity
  • Optional HLA/KIR panel
  • Infusion-ready formulation
Method · Phenotyping by cytometry + cytotoxicity assay.
Muse Cells — Stress-tolerant pluripotency.

Next generation

Muse Cells — Stress-tolerant pluripotency.

SSEA-3+ subpopulation with trilineage differentiation capacity.

  • SSEA-3+ enriched
  • Directed homing to injured tissue
  • Reported low tumorigenicity
  • Standardized per-dose presentation
Method · SSEA-3 marker selection and cytometry verification.
Peptides & Factors — Molecular precision.

Targeted signaling

Peptides & Factors — Molecular precision.

High-purity synthetic sequences for targeted signaling.

  • HPLC purity ≥ 98%
  • Mass spectrometry verified
  • Endotoxins < 0.25 EU/mg
  • Pharmaceutical-grade sterile fill
Method · HPLC + MALDI-TOF per batch.

Quality process

From lab to clinic, with zero blind spots.

  1. Step 1

    Reception

  2. Step 2

    Cytometry

  3. Step 3

    Quality control

  4. Step 4

    Release with COA

  5. Step 5

    Cold chain

Numbers

One standard. Every batch.

0%
Minimum viability
0%
Batches with COA
0h
Average delivery
0
Biologic families

Medical & scientific board

Curated together with physicians and researchers.

Dr. Alejandro Reyes

Dr. Alejandro Reyes

Regenerative Medicine · Co-founder

Dra. María Fernanda Cruz

Dra. María Fernanda Cruz

PhD Cell Biology · Quality

Dr. Ignacio Solís

Dr. Ignacio Solís

Clinical Immunology · Advisor

References

Scientific citations

  1. Dominici M, et al. Minimal criteria for defining multipotent MSCs. Cytotherapy. 2006.
  2. Théry C, et al. MISEV2018 guidelines for extracellular vesicles. J Extracell Vesicles. 2018.
  3. Vivier E, et al. Innate lymphoid cells and NK biology. Science. 2011.
  4. Kuroda Y, et al. Muse cells: pluripotent stress-tolerant stem cells. PNAS. 2010.
  5. ICH Q5A(R2). Viral safety evaluation of biotechnology products. 2023.

Science ready for your clinic.

Request professional access and download full technical sheets.

Request an account

Information for licensed health professionals. Not a treatment indication.